In general, β-blockers are well tolerated, but serious side effects may occur, which are usually associated with the β2-AR antagonistic activity (e.g., increase in peripheral vascular resistance, worsening of asthma symptoms) [27]. This evidence concerns the gene ADRB2 and asthma.